CompletedInterventionalPhase 4Last updated Feb 2, 2023

Comparison of Insulin Glargine and Regular Insulin Versus NPH and Regular Insulin in the Treatment of T1DM

Comparison of Insulin Glargine Mixed With Regular Insulin Versus the Standard Neutral Protamine Hagedorn (NPH) and Regular Insulin in the Treatment of Type 1 Diabetes Mellitus

Overview

ClinicalTrials.gov ID: NCT05709938
Lead Sponsor: King Edward Medical UniversityOTHER
Brief Summary: To compare the glycemic control in children with type 1 diabetes using insulin Glargine and regular insulin as basal bolus therapy versus Neutral Protamine Hagedorn insulin (NPH) and regular insulin.
Study Type: Interventional

Status

Overall Status: Completed
Start Date: Nov 1, 2019Actual
Primary Completion Date: Jan 5, 2021Actual
Completion Date: Apr 20, 2021Actual

Study Record Dates

First Submitted: Jan 14, 2023
First Submitted that Met QC Criteria: Jan 29, 2023
First Posted: Feb 2, 2023Actual
Last Update Submitted that Met QC Criteria: Jan 29, 2023
Last Update Posted: Feb 2, 2023Actual
Last Verified: Jan 2023

NCT01223131Completed

Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old.

NCT02189395Terminated

Comparison of Neutral Protamine Hagedorn (NPH) and Lantus Based Insulin Regimen in the Management of Hypoglycemia in the Hospitalized Patients in Noncritical Care Setting

NCT00115570Completed

Comparison of the Ability of Glulisine With Lispro to Control Type 1 Diabetes Mellitus in Children and Adolescents

NCT01854723Withdrawn

Comparison Study of Insulin Glargine and NPH Insulin

NCT00993473Completed

6-month Comparison of Morning Lantus Versus Neutral Protamine Hagedorn Insulin in Young Children With Type 1 Diabetes

NCT00949442Completed

Lantus Versus NPH: Comparison in Insulin Naive People Not Adequately Controlled With at Least One Oral Anti Diabetics (OAD) Treatment